Revenue for Quest Diagnostics (DGX)
According to Quest Diagnostics's latest reported financial statements, the company's current revenue (TTM) is $11.28B USD. Revenue is the total income from selling goods or services before any expenses. Unlike net income (earnings), revenue does not subtract operating costs, taxes, or other charges. Figures are in USD; chart and tables below use historical filings (not a live revenue-per-second estimate).
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
Currently viewingRevenueSwitch metric
TTM (last 4 quarters)
$11.28B
YoY change
+11.8%
5Y CAGR
+3.2%
Peak year (2025)
$11.04B
Cumulative revenue
$196.10B
Revenue history chart for Quest Diagnostics (DGX) from 1996 to 2025
Revenue history table for Quest Diagnostics (DGX) from 1996 to 2025
| Fiscal year | Period ended | Reported | Revenue | YoY |
|---|---|---|---|---|
| 2025 | $11.04B | +11.8% | ||
| 2024 | $9.87B | +6.7% | ||
| 2023 | $9.25B | -6.4% | ||
| 2022 | $9.88B | -8.4% | ||
| 2021 | $10.79B | +14.3% | ||
| 2020 | $9.44B | +22.1% | ||
| 2019 | $7.73B | +2.6% | ||
| 2018 | $7.53B | -2.3% | ||
| 2017 | $7.71B | +2.6% | ||
| 2016 | $7.51B | +0.3% | ||
| 2015 | $7.49B | +0.8% | ||
| 2014 | $7.43B | +4.0% | ||
| 2013 | $7.15B | -3.2% | ||
| 2012 | $7.38B | -1.7% | ||
| 2011 | $7.51B | +1.9% | ||
| 2010 | $7.37B | -1.2% | ||
| 2009 | $7.46B | +2.8% | ||
| 2008 | $7.25B | +8.1% | ||
| 2007 | $6.70B | +7.0% | ||
| 2006 | $6.27B | +13.9% | ||
| 2005 | $5.50B | +7.4% | ||
| 2004 | $5.13B | +8.2% | ||
| 2003 | $4.74B | +15.3% | ||
| 2002 | $4.11B | +13.2% | ||
| 2001 | $3.63B | +6.0% | ||
| 2000 | $3.42B | +55.1% | ||
| 1999 | $2.21B | +51.2% | ||
| 1998 | $1.46B | -4.6% | ||
| 1997 | $1.53B | -5.4% | ||
| 1996 | $1.62B | — |
Revenue values are taken from Quest Diagnostics's reported income statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
2025's annual revenue for Quest Diagnostics (DGX) came in at $11.04B – grew 11.8% year-over-year.
Quest Diagnostics revenue compound annual growth for the 2020–2025 (5 years) window is +3.2%, sustaining 2 straight years of year-over-year growth.
The dataset's maximum revenue sits at $11.04B (2025); the minimum reading of $1.46B dates to 1998.
Quest Diagnostics (DGX) sits 9th of 8 Healthcare peers we track on this metric, against a peer median of $65.09B.
Quest Diagnostics Revenue by Year
Quest Diagnostics Revenue 2025: $11.04B
Quest Diagnostics revenue in 2025 was $11.04B, grew 11.8% from 2024. This figure represents the highest annual value in the available history.
Quest Diagnostics Revenue 2024: $9.87B
Quest Diagnostics revenue in 2024 was $9.87B, grew 6.7% from 2023.
Quest Diagnostics Revenue 2023: $9.25B
Quest Diagnostics revenue in 2023 was $9.25B, declined 6.4% below 2022.
Quest Diagnostics Revenue 2022: $9.88B
Quest Diagnostics revenue in 2022 was $9.88B, declined 8.4% below 2021.
Quest Diagnostics Revenue 2021: $10.79B
Quest Diagnostics revenue in 2021 was $10.79B.
See more financial history for Quest Diagnostics (DGX).
Sector peers — Revenue
Companies in the same sector as Quest Diagnostics, ranked by their latest revenue.
| Company | Revenue | Sector |
|---|---|---|
| UnitedHealth Group Incorporated (UNH) | $447.57B | Healthcare |
| Novo Nordisk A/S (NVO) | $309.06B | Healthcare |
| Johnson & Johnson (JNJ) | $94.19B | Healthcare |
| Eli Lilly and Company (LLY) | $65.18B | Healthcare |
| Merck & Co., Inc. (MRK) | $65.01B | Healthcare |
| AbbVie Inc. (ABBV) | $61.16B | Healthcare |
| AstraZeneca PLC (AZN) | $58.74B | Healthcare |
| Amgen Inc. (AMGN) | $36.74B | Healthcare |
Frequently asked questions
What is Quest Diagnostics's revenue?
- Latest reported revenue for Quest Diagnostics (DGX) is $11.28B (period ending March 31, 2026).
How has Quest Diagnostics revenue changed year-over-year?
- Quest Diagnostics (DGX) revenue changed +11.8% year-over-year on the latest annual filing.
What is the long-term growth rate of Quest Diagnostics revenue?
- Quest Diagnostics (DGX) revenue compound annual growth rate is +3.2% over the most recent 5 years available.
When did Quest Diagnostics revenue hit its highest annual value?
- Quest Diagnostics revenue reached its highest annual value of $11.04B in 2025.
What was Quest Diagnostics revenue in 2024?
- Quest Diagnostics (DGX) revenue in 2024 was $9.87B.
What was Quest Diagnostics revenue in 2025?
- Quest Diagnostics (DGX) revenue in 2025 was $11.04B.
Metrics overview
Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.
Explore more
DGX Overview
Company profile, financial tools, and key metrics
DGX Revenue Counter
Earns $357.62 every second. See per minute, hour, and day.
DGX Earnings Counter
Earns $32.47 per second net profit. See per minute, hour, and day.
DGX Economic Scale
Exceeds Monaco's GDP. Compare with world economies.
DGX What If Invested
What if you had invested $1,000? See historical returns from any date.
DGX How It Makes Money
Discover visual breakdown of $11.28B in revenue — where it comes from and where it goes.
DGX Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
DGX Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
DGX Daily Price Character
Steady · 50.6% historical win rate (green days). Streaks & record days.
DGX Buybacks
2.09% TTM buyback yield. Shareholder yield & SBC comparison.
DGX Stock Split History
2 splits on record. Dates, ratios, and cumulative multiple.
DGX Dividend Profile
Yield: 1.72%. Safety: 5/8. See full history.
DGX Dividend Calculator
How much dividend income would $1,000 have earned? Calculate from any date.
DGX Dividend Forecast
Project future income with DRIP, growth assumptions, and optional monthly contributions.